Bristol pharmaceuticals startup bought for £623 million

Imported from official source

University spin-out - supported by UK Research and Innovation funding - acquired to develop 'groundbreaking' treatment for diabetes.

This version

Version
1 of 1
Recorded
September 20, 2026 19:53
Change
Initial
Content hash
e834318cef44fb5fd527a57b6382cff5
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.